nach phase 3 einstellung absturz von 95%
Seite 1 von 2 Neuester Beitrag: 25.04.21 02:28 | ||||
Eröffnet am: | 29.03.18 12:12 | von: Claudimal | Anzahl Beiträge: | 44 |
Neuester Beitrag: | 25.04.21 02:28 | von: Yvonnesuyha | Leser gesamt: | 12.851 |
Forum: | Hot-Stocks | Leser heute: | 1 | |
Bewertet mit: | ||||
Seite: < 1 | 2 > |
fette news gestern nachbörslich.dürfte heute ordentlich uppen.shorrties+zocker.
Sturm im Wasserglas
Fallt nicht darauf rein! Die haben fertig! Alles nur Gezocke!
https://seekingalpha.com/news/...iscloses-study-data-strategic-update
- MK 22 Mio. $
- Cash Ende Q3/18 ~ 37 Mio. $
- Cash-burn pro Quartal ~ 5 Mio. $
- Schulden 7 Mio. $
- Anzahl Aktien 31 Mio. Stück
- 30 Mio. $ / 31 Mio. Stück = 0,97$ Cash pro Aktie
- Zielkurs 0,97$
- Potenzial +39%
Review of Strategic Alternatives
"Edge continues to be actively engaged in its review of strategic alternatives to maximize stockholder value, a review that was announced in April 2018. At that time, Edge retained Piper Jaffray & Co. to act as its financial advisor to assist with this review process. Potential strategic alternatives that may be explored or evaluated as part of this review include, but are not limited to, an acquisition, merger, business combination or other strategic transaction involving Edge. Edge has reduced the scope of its operations, including the size of its workforce, in order to preserve its cash resources during the strategic alternatives review process"
http://investors.edgetherapeutics.com/...l-newsArticle&ID=2374636
Merger mit PDS Biotechnology abgeschlossen
http://investors.edgetherapeutics.com/...l-newsArticle&ID=2391536